|
|
Volumn 1, Issue 1, 2008, Pages 17-28
|
|
Role of bortezomib for the treatment of previously untreated multiple myeloma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
PROTEASOME;
PYRAZINE DERIVATIVE;
ARTICLE;
AUTOTRANSPLANTATION;
CLINICAL TRIAL (TOPIC);
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG COMBINATION;
HUMAN;
METABOLISM;
MULTIPLE MYELOMA;
STEM CELL TRANSPLANTATION;
ANTINEOPLASTIC AGENTS;
BORONIC ACIDS;
CLINICAL TRIALS AS TOPIC;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
HUMANS;
MULTIPLE MYELOMA;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PYRAZINES;
STEM CELL TRANSPLANTATION;
TRANSPLANTATION, AUTOLOGOUS;
|
|
EID: 77953512119
PISSN: None
EISSN: 17474094
Source Type: Journal
DOI: 10.1586/17474086.1.1.17 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
